| Emma Elizabeth Skerl, DO | |
|
214 W Bowery St, Akron, OH 44308-1046 | |
| (330) 543-1000 | |
| Not Available |
| Full Name | Emma Elizabeth Skerl |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 214 W Bowery St, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033813233 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 58.033406 (Ohio) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emma Elizabeth Skerl, DO 17497 Woodshire Dr, Strongsville, OH 44149-6029 Ph: (440) 226-1359 | Emma Elizabeth Skerl, DO 214 W Bowery St, Akron, OH 44308-1046 Ph: (330) 543-1000 |
News Archive
Equinix, Inc., a provider of global data center services, and Carpathia Hosting, a provider of complex, compliant managed hosting services for government agencies and enterprises, today announced plans to build a 64,000 square foot data center in Dulles, Va. aimed at supporting industry-specific compliant solutions for healthcare companies, federal agencies, and commercial industries.
Approximately 60 percent of people experience epistaxis, commonly known as nosebleed, at least once in their lifetime. Of those who experience nosebleed, six percent require medical treatment. A study in the September 2013 issue of Otolaryngology-Head and Neck Surgery, explores which nosebleed treatment options demonstrate the best outcomes.
Just thinking that a medicine will relieve pain is enough to prompt the brain to release its own natural painkillers, and soothe painful sensations, a new University of Michigan study finds.
Atrium Medical Corporation and Kaneka Corporation are proud to announce the introduction of the Xpress-Way RX Extraction Catheter. Xpress-Way RX has recently received FDA 510K clearance and is indicated for the removal of fresh, soft emboli and thrombi from vessels in the coronary and peripheral vasculature.
Researchers at the Uniformed Services University of the Health Sciences Center for Prostate Disease Research, in collaboration with investigators at the Armed Forces Institute of Pathology and Walter Reed Army Medical Center, have developed a highly specific assay for the detection of ERG, a protein associated with tumor formations which is present in more than half of all prostate cancers.
› Verified 8 days ago